Stocks
Novartis (NVS) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 33.8% | 31.6% | 39.1% | 40.1% | 41.9% | 40.0% | ||
| Changes by years, y/y, % | +2pp | -2pp | +8pp | +1pp | +2pp | +6.6% | |||
Novartis. EBITDA margin, %
Novartis. EBITDA margin, changes, pp
Novartis (NVS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 42.8% | 41.0% | 40.7% | 38.0% | 40.0% | 40.0% | |
| Changes by years, y/y, % | +4pp | +0pp | -2pp | 0pp | -3pp | |||
| Changes by quarters, q/q, % | +5pp | -2pp | 0pp | -3pp | +2pp | |||
